Back to Results

Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis (StopRA)

Study category: Bones, Muscles, and Joints

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Eligibility

CCP positive individuals without Rheumatoid Arthritis

Phase

II - Research Studies that gather preliminary data on whether a drug works in people who have a certain condition/disease (that is, the drug's effectiveness). For example, participants receiving the drug may be compared to similar participants receiving a different treatment, usually an inactive substance (called a placebo) or a different drug. Safety continues to be evaluated, and short-term adverse events are studied.

Type of Study

Prevention

Scope

National

Locations

Barbara Davis Center
UCD Barbara Davis Center
University of Colorado Hospital

Principal Investigator
Kevin Deane,  MD

Kevin Deane, MD

Study ID

Protocol Number: 15-1868

More information available at ClinicalTrials.gov: NCT02603146

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers